Advanced percutaneous and surgical procedures in structural and congenital heart disease require precise pre-procedural planning and continuous quality control. Although current imaging modalities and post-processing software assists with peri-procedural guidance, their capabilities for spatial conceptualization remain limited in two-and three-dimensional representations. In contrast, 3D printing offers not only improved visualization for procedural planning, but provides substantial information on the accuracy of surgical reconstruction and device implantations. Peri-procedural 3D printing has the potential to set standards of quality assurance and individualized healthcare in cardiovascular medicine and surgery. Nowadays, a variety of clinical applications are available showing how accurate 3D computer reformatting and physical 3D printouts of native anatomy, embedded pathology, and implants are and how they may assist in the development of innovative therapies. Accurate imaging of pathology including target region for intervention, its anatomic features and spatial relation to the surrounding structures is critical for selecting optimal approach and evaluation of procedural results. This review describes clinical applications of 3D printing, outlines current limitations, and highlights future implications for quality control, advanced medical education and training.
Introduction
With increasing complexity of cardiac conditions, current surgical and interventional procedures require advanced peri-procedural imaging and sometimes even tactile testing to become as safe, expedient, and well-tolerated for patients. 1 Nowadays, volume rendering based on three-dimensional (3D) data sets may be obtained from computed tomography (CT), magnetic resonance imaging (MRI), and 3D echocardiography portrayed on a twodimensional (2D) monitor. In the light of increasing individualization in cardiovascular medicine and surgery, conventional 3D imaging alone is not as effective as having a physical model identical to patient's anatomy, particularly prior to highly complex procedures. 2, 3 Physical models derived from 3D printing, also referred to as 'additive manufacturing' and 'rapid prototyping' are not limited by their dependence on electronic storage media and computers but provide operators with tactile experience and allow simulation of procedures. 4 After almost three decades of experience with medical 3D printing, this technology is now being used to create even very complex models as needed in cardiovascular medicine and surgery. 5 How to derive 3D models from conventional imaging data?
Volume rendering from 3D data sets displayed on a 2D screen represents the current gold standard of 3D imaging based on Digital Imaging and Communications in Medicine (DICOM) data files. As a first step of the workflow ( Figure 1 ) through to 3D printouts, objects of interest are selected and separated within 3D data sets. This process is called 'segmentation' and is done in DICOM standard. However, DICOM image files cannot be utilized by 3D printers and therefore, have to be converted into another standard called Standard Tessellation Language (STL). This format defines surfaces of anatomic structures as composed of small triangles that fit together like a spatial puzzle. Before 3D-printing can start, STL models have to be postprocessed accordingly. 6 
Segmentation
The process of segmentation allows for the separation of the different structures and individual cardiac chambers from the CT and MRI derived 3D volume datasets (DICOM) using a reconstructed model obtained from 2D CT and MRI slices. 7 The use of contrast agents allows for the differentiation of intravascular and intracardiac volumes. The blood pool displays high signal intensity different from the lower intensities of the adjacent tissue, thus delineating the endoluminal contours. The further process is semi-automated with specific software algorithms using signal threshold, boundaries detection, and regional identification. 8 These variables are crucial for the quality of the segmented images, however, some degree of visual editing is always required for confirmation that all structures have been properly delineated and that the geometry created is an accurate representation of the true anatomy. The segmented 3D image file and the structures of interest can then be prepared for printout in different colours depending on the area being targeted. Segmentation from 3D echocardiographic DICOM files requires specific software. Although segmentation of the heart from surrounding tissues based on echocardiography remains challenging, high-quality segmentation inside the heart and in particular segmentation of valvular structures using 3D data sets acquired by transoesophageal echocardiography (TEE) seems to stand out. 9, 10 Data acquisition by CCT, MRI or echocardiography should be generally done in accordance to standard protocols. The use of intravenous contrast material is integral component of CT and MRI-based angiographic acquisition protocols.
Fixing and design
Conversion from DICOM to STL format often leaves gaps and small overlaps of the surface. 
Cardiac 3D casts
A variety of printing techniques and materials are available, which are increasingly well adapted to the needs in cardiovascular medicine and surgery:
• Stereolithography represents an early technique based on a layer by layer photopolymerization. This technique reveals transparent or non-transparentrigid printouts and is, therefore, not ideal for purposes in cardiovascular medicine.
• Selective Laser Sintering (SLS) considered an outclassing technology uses laser as a power source to sinter powdered material. This technique enables 3D printing of delicate cardiac structures, e.g. native valves. Its dissemination is still limited owing to high production costs.
• Binder Jetting, a technique that creates artefacts through inkjet printing of binder into a powder bed of raw material, provides with rigid and non-transparent printouts. It is capable of printing substructures, e.g. ventricles, atria and large vessels in different colors ( Figure 2 ).
• PolyJet Technology provides with dual-material printouts combining smooth, soft and transparent material with hard and nontransparent components ( Figure 3 ). The advantage of this technique is its capability of printing pathology or implants being visible through surrounding native tissue.
• Fused Deposition Modelling also known as Fused Filament Fabrication or Plastic Jet Printing utilizes melted thermoplastic material being supplied layer by layer as the material hardens immediately after extrusion from a nozzle which can turn the flow on and off.
Printing time varies from about three hours for distinct cardiac structures to a full day for full hearts. It also depends on printing velocity, which is determined by slice thickness, percentage of model filling and quality of the printer. Costs of 3D printing are still considerable and start at lower four-digit amounts in e but depend very much on the institutional volume of 3D modelling and on the quality of the equipment used.
Peri-interventional 3D printing in structural heart disease Benefits of peri-interventional 3D printing have been shown for transcatheter aortic valve implantation (TAVI), MitraClip V R implantation as well as device closure of atrial septal defect (ASD) and left atrial appendage (LAA).
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Personalized TAVI Dual-material 3D printing based on CCT derived data sets using modified PolyJet technology is considered most appropriate to create 
patient-specific models of degenerative aortic stenosis (AS) enabling to explore individual anatomical characteristics ( Figure 3) . In particular, the unique pattern and distribution of calcium deposition can be exactly replicated. 11 Individual haemodynamics as well as deployment of transcatheter heart valves can be simulated using 3D printed valve models. 7, 12 That way, implants can be tested and optimal prosthetic valve size and balloon inflation volume determined to avoid paravalvular leaks and annulus rupture. Models precisely show the spatial relation between transcatheter heart valve and surrounding native structures as are left ventricular outflow tract, mitral annulus and coronary ostia ( Figure 4) . In difficult anatomy, e.g. extreme porcelaine aorta and peri-valvular calcification, 13 and possibly prior to valve-invalve implantation, this approach may help to achieve optimal longterm results after TAVI. Pre-and post-procedural virtual and real 3D 
printing also seems to facilitate quality management and medical education.
Patient-specific mitral valve interventions
Percutaneous mitral valve repair using the MitraClip V R system may be considered in symptomatic but inoperable patients with severe primary (degenerative) or secondary (functional) mitral regurgitation despite optimal therapy. 14, 15 TEE is recommended to optimally prepare for the procedure and to guide the procedural steps oneto-one 16 and TEE derived 3D data sets are very useful for pre-procedural 3D printing of the native valve and post-procedural printing of the interventional result 17 ( Figure 5) . The integration of multiple imaging modalities also known as Hybrid 3D Printing 3 enables creating accurately printed heart models including detailed valvular pathology. Therefore, 3D echocardiographic data sets are combined with those derived from CCT or MRI. The use of dedicated closure devices to occlude para-valvular leaks or mitral leaflet perforation requires individual procedural planning and might also be optimized by use of pre-interventional 3D printing. 17 Patient-specific 3D printed cardiac reconstruction is promising for emerging transcatheter mitral valve implantation and repair techniques that are currently under investigation.
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ASD and LAA device closure
Virtual (computer generated) and tangible (physical) 3D printouts of ASDs can be used to make sure that sufficient rim is available to firmly fix closure devices. After device deployment 3D models are useful to confirm the occluder to adequately fill the ASD and both countercluders to not interfere with venous inlets and to be as perfectly aligned as possible with the interatrial septum. 19 Unfavourable interference between the device and surrounding native structures, e.g. the aortic wall or the left atrial roof, can be excluded ( Figure 6 ). Procedural planning for LAA closure is even more challenging than for device closure of interatrial communications, since the complex dimensions of this structure and its variable morphology may easily result in complications or procedural failure. Using 3D models of the native LAA derived from CCT or TEE data sets the engagement of those devices can be tested prior to the procedure 20, 21 what may reduce the risk of malposition particularly in complex anatomy. 22 Closure device sizing and selection may be improved and proceeding with a dedicated device prospectively discouraged or encouraged. 23 After device deployment, personalized 3D-printed cardiac reconstruction can also help with post-interventional fault isolation and procedural optimization ( Figure 7) .
Applications in electrophysiology
With the development of 3D electro-anatomical mapping systems, safe and minimaly invasive treatment of complex arrhythmias became possible. The visualization in 3D models increases our understanding of the arrhythmia substrate, and together with analysis of the electrical conduction properties of cardiac tissue, one can target focal and re-entrant arrhythmias effectively. 24 Use of 3D printing prior to atrial fibrillation ablation includes the assessment of the left atrium, pulmonary veins and LAA. Understanding of spatial anatomy allows the operator to choose the type of catheters, sheaths and energy (radio-frequency vs. cryo-thermal) suited for each patient's unique morphology. Pre-procedural anatomical delineation of scar tissue provided by 3D printing is crucial to localize potential substrates for ablation. 25 Identifying scar substrates on a 3D model could help in selecting the right access (endocardial, epicardial, or combined) and type of catheter required for a successful ablation. Ablation of idiopathic arrhythmias arising from structures such as papillary muscles, aortic cusps and the right ventricular moderator band could be better guided. In cardiac resynchronization therapy, having a 3D model of the coronary sinus and its tributaries preoperatively could allow the physician to 'test' potential vein targets and tools and find those suited best for a patient's given anatomy. Having a preprocedural 'road map' can minimize procedural time and increase the likelihood of procedural success. Finally, 3D printing of heart models allow for labelling of specific structures (such as the sinoatrial and atrioventricular nodes) and cross-sectioning to select optimal views of target structures. Models could also be used for teaching and to train physicians to properly manipulate and navigate catheters and leads before undertaking procedures.
Peri-operative 3D printing
Patients with complex heart disease and in particular those after corrective or palliative surgery have a great variety of morphology what entails that actual anatomic structures may be unpredictable despite excellent conventional preoperative imaging. Peri-operative planning and decision-making in those cases considered complex and nonroutine require spatial anatomic orientation which cannot be easily extrapolated from medical experience. 4 
Congenital heart disease
That applies to patients after paediatric cardiac surgery and to adult patients with native congenital heart disease. A number of case reports have demonstrated preoperative printing to be helpful in the operation room. Models of the entire heart or a single cardiac and vascular structure can be sterilized and directly taken into surgery. Life-like replicas of congenital malformations ( Figure 2 ) help decision making for choosing an individual treatment strategy, for example minimizing the surgical access sites and with intra-operative orientation. 26 Conceptualization and displaying spatial dimensions of defects, e.g. ventricular septal defects (VSDs), facilitates corrective surgery, and eventually accelerates the procedure. 4 In VSDs, 3D Figure 8 Mitral valve prolapse of the P2 segment printed by Selective Laser Sintering (TomTec GmbH, Munich, Germany) after segmentation from 3D echocardiographic data. AML, anterior mitral leaflet; P2P, prolapse of the P2 segment of the PML; RO, regurgitant orifice. model measurements correspond to those obtained from conventional echocardiography. 9 Exact information on size and shape of vessels, e.g. of the aorta, pulmonary arteries and veins, brachiocephalic vein, superior and inferior vena cava, Glenn shunts, Fontan operation, etc. is also important prior to and during palliative surgery or even heart transplantation. 27 Ventricular assist devices are underutilized in adults with congenital heart disease due to their complex anatomy and physiology. This is especially the case in patients with systemic right ventricle who mostly develop heart failure during the fifth decade of life. 28 Patients with Fontan failure may need ventricular assist devices and possibly heart transplantation. 29 Preoperative planning of cannulation and device placement as well as connecting individual morphology with assist devices are enabled and facilitated 30 with 3D models. Although replicas displaying congenital defects are mostly created from CT or MRI based image files, Hybrid 3D Printing including echocardiography derived data sets has also a role if atrioventricular valves are involved into pathology. 31 
Modelling of valve disease
Modelling of mitral leaflet and annular pathology as well as replicating precise tissue properties and behaviour still remains a challenge even if 3D printing based on 3D echocardiographic data seems to be more suitable for modelling of valves then CT or MRI data sets. 10 Nevertheless, SLS derived valve models might be taken into the operation room to guide through surgical procedures ( Figure 8 ). Valve models of AS and those showing particular mitral regurgitation mechanisms are useful for preoperative patient-specific haemodynamic testing 12 what potentially helps with developing a superior surgical plan well before the first incision. 10 This strategy is also known as functional modelling and can be also applied for advanced training.
Miscellaneous
Resternotomy after previous bypass grafting still has potential risks due to accidental injury of mediastinal structures including vein grafts and the internal mammary artery. Printing of a 3D model has been reported to minimize those risks and to optimize surgical planning and intra-operative decision-making. 4 In patients with left ventricular aneurysm and primary cardiac tumours, differential therapy includes total and partial resection as well as heart transplantation. 32 This decision and intra-operative orientation are often difficult due to lacking spatial conceptualization. Stereolithography 33 and PolyJet Technology were shown to replicate hearts with primary cardiac tumour ( Figure 9 ) and aneurysm and to clearly demarcate pathology from healthy myocardium. 4 Although myectomy in hypertrophic cardiomyopathy is associated with low mortality, complex left ventricular outflow tract anatomy, anomalies of the papillary muscle, and limited intra-operative view in the surgical field may be challenging. As shown for tumour resection 3D modelling provides with intuitive information on left ventricular geometry including the extent of the hypertrophied interventricular septum and location of the papillary muscle. 34 Clinical benefits are likely in all surgical cases presenting with highly individual morphology, e.g. in pulmonary atresia 35 or diseases of the aortic arch 36 due to improved orientation, optimized pre-surgical decision-making and simulation of the procedure.
Discussion
True 3D representation of native cardiac structures, acquired pathology and results of procedural interventions are achievable by creating tangible models, 37 although the technique still lacks scientific evidence. Thereby, 3D printing potentially has impact on detailed procedural planning 38 rather than on principal clinical decision making in favour of or against particular procedures.
What makes the difference between 3D imaging and printing?
There are limited reports 4,9 and a few case series, which have compared 3D imaging and 3D printing. Most anecdotal reports convey the tactile feeling of 3D modelling is an advantage over images alone.
There is some evidence supporting 3D printing to be superior to imaging. Spatial structures projected by use of conventional 3D imaging modalities obviously do not effectively communicate to the observer, since human visuo-spatial skills, i.e. 'mental rotation' and 3D conceptualization are limited 39 and vary significantly between individuals. 5 Modelling eliminates these limitations and leaves no aspect of any spatial relationship to the imagination of the observer. 
Does 3D printing improve outcome of care?
The answer to this question is still pending. Although preoperative tactile experience, the opportunities of simulating surgery and to test implants for appropriateness prior to percutaneous interventions promise a vast future of this technology, even though no controlled trials have yet shown outcome data or cost savings. Clinical benefits, e.g. improved safety and better long-term results, and cost reduction in care are possible. Nevertheless, even small cost savings from a surgeon knowing the anatomy precisely before opening the chest might provide a cost benefit from an improvement of safety and outcomes.
Future perspectives-3D bioprinting
Limited visibility to target region is inherent to many new procedures currently being under development. In that regard introduction and refinement of those innovative therapies might be facilitated by 3D printing which is deemed most beneficial in highly specific procedures and in individual anatomy. Prospective, multicentre clinical trials are urgently needed to verify accuracy of 3D printing and clinical benefit in order to justify reimbursement and to make the technology available for patients presenting with challenging heart conditions. Another group of techniques also known as 3D bioprinting are thought to build engineered tissue constructs with complex and hierarchical structures, mechanical, and biological heterogeneity. 40 New bionic materials include cell suspensions, cellladen hydrogels, decellularized matrix components, microcarriers offering particular surface areas for quick cell attachment and scaffold-free cell spheroids enabling generation of more mature tissue constructs. However, despite of great progress in research, there are still many challenges that prevent transition of these techniques to clinical applications.
Conclusions
Three-dimensional models derived from conventional 3D image files may to prepare for individualized treatment in complex cardiovascular anatomy. They provide users with the ability to manipulate the model and to 'test' catheters and devices in a 'simulation' of how the procedure would be performed and how a catheter or device would be manipulated and deployed inside the patient's unique cardiac anatomy. Although hard endpoint data are still pending, 3D printing seems to support quality management and education in cardiovascular medicine and surgery.
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